A characterization of genetic variants in BRCA1 intron 8 identifies a mutation and a polymorphism

被引:8
作者
Pyne, MT [1 ]
Pruss, D [1 ]
Ward, BE [1 ]
Scholl, T [1 ]
机构
[1] Myriad Genet Labs, Salt Lake City, UT 84108 USA
来源
MUTATION RESEARCH-GENOMICS | 1999年 / 406卷 / 2-4期
关键词
BRCA1; splice; mutation;
D O I
10.1016/S1383-5726(99)00006-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The biochemical and genetic characterizations of two variants that occur in BRCA1 intron 8 are presented. The variant IVS8 + 2T --> C induces an aberrant transcript that deletes exon 8. This exon-skipping deletion disrupts the open reading frame by juxtaposing exon 7 and exon 9 in the aberrant splice product. Theoretically, 50 abnormal residues from reading frame 2 are translated following exon 7 before a stop codon is encountered. The chromosomal contribution to the relevant RNA species was tracked using a silent polymorphism at codon 694 (serine AGC or AGT). Nucleotide sequencing of this polymorphic codon demonstrated that the aberrant transcript was derived solely from the chromosome encoding AGT. The normally spliced productive transcript also displayed loss of heterozygosity and was derived solely from the chromosome encoding AGC at codon 694. Also, a haplotype analysis using a breast cancer patient database showed that the chromosome bearing serine 694-AGT carried IVS8 + 2T --> C, A second more common variant, IVS8-58delT, was characterized as a polymorphism. Analysis of RNA from patient samples used the same silent polymorphism at codon 694 and showed that the normal massage was derived from both chromosomes. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 15 条
[1]  
*BIC, 1998, BREAST CANC INF COR
[2]   Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5′ splice site at the mutant codon in cerebrotendinous xanthomatosis patients [J].
Chen, W ;
Kubota, S ;
Teramoto, T ;
Nishimura, Y ;
Yonemoto, K ;
Seyama, Y .
BIOCHEMISTRY, 1998, 37 (13) :4420-4428
[3]   A G→A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2 [J].
De Klein, A ;
Riegman, PHJ ;
Bijlsma, EK ;
Heldoorn, A ;
Muijtjens, M ;
den Bakker, MA ;
Avezaat, CJJ ;
Zwarthoff, EC .
HUMAN MOLECULAR GENETICS, 1998, 7 (03) :393-398
[4]  
EASTON DF, 1993, AM J HUM GENET, V52, P678
[5]   CONFIRMATION OF BRCA1 LAY ANALYSIS OF GERMLINE MUTATIONS LINKED TO BREAST AND OVARIAN-CANCER IN 10 FAMILIES [J].
FRIEDMAN, LS ;
OSTERMEYER, EA ;
SZABO, CI ;
DOWD, P ;
LYNCH, ED ;
ROWELL, SE ;
KING, MC .
NATURE GENETICS, 1994, 8 (04) :399-404
[6]  
Hoffman JD, 1998, AM J MED GENET, V80, P140, DOI 10.1002/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.3.CO
[7]  
2-C
[8]  
Lu ML, 1996, CANCER RES, V56, P4578
[9]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[10]  
Neuhausen SL, 1996, AM J HUM GENET, V58, P271